207 related articles for article (PubMed ID: 37103365)
1. Marine-Derived Lead Fascaplysin: Pharmacological Activity, Total Synthesis, and Structural Modification.
Wang C; Wang S; Li H; Hou Y; Cao H; Hua H; Li D
Mar Drugs; 2023 Mar; 21(4):. PubMed ID: 37103365
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in the Synthesis of the Marine-Derived Alkaloid Fascaplysin and Its Metabolites Homofascaplysins A-C.
Mittapalli RR; Kumari H
Molecules; 2024 Apr; 29(7):. PubMed ID: 38611869
[TBL] [Abstract][Full Text] [Related]
3. A New Mild Method for Synthesis of Marine Alkaloid Fascaplysin and Its Therapeutically Promising Derivatives.
Tryapkin OA; Kantemirov AV; Dyshlovoy SA; Prassolov VS; Spirin PV; von Amsberg G; Sidorova MA; Zhidkov ME
Mar Drugs; 2023 Jul; 21(8):. PubMed ID: 37623705
[TBL] [Abstract][Full Text] [Related]
4. Chemistry and biology of fascaplysin, a potent marine-derived CDK-4 inhibitor.
Bharate SB; Manda S; Mupparapu N; Battini N; Vishwakarma RA
Mini Rev Med Chem; 2012 Jun; 12(7):650-64. PubMed ID: 22512549
[TBL] [Abstract][Full Text] [Related]
5. Study of Structure-Activity Relationships of the Marine Alkaloid Fascaplysin and Its Derivatives as Potent Anticancer Agents.
Zhidkov ME; Kaune M; Kantemirov AV; Smirnova PA; Spirin PV; Sidorova MA; Stadnik SA; Shyrokova EY; Kaluzhny DN; Tryapkin OA; Busenbender T; Hauschild J; Rohlfing T; Prassolov VS; Bokemeyer C; Graefen M; von Amsberg G; Dyshlovoy SA
Mar Drugs; 2022 Mar; 20(3):. PubMed ID: 35323484
[TBL] [Abstract][Full Text] [Related]
6. Fascaplysin Sensitizes Anti-Cancer Effects of Drugs Targeting AKT and AMPK.
Oh TI; Lee JH; Kim S; Nam TJ; Kim YS; Kim BM; Yim WJ; Lim JH
Molecules; 2017 Dec; 23(1):. PubMed ID: 29295560
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a marine-derived bis-indole alkaloid fascaplysin, as a new class of potent P-glycoprotein inducer and establishment of its structure-activity relationship.
Manda S; Sharma S; Wani A; Joshi P; Kumar V; Guru SK; Bharate SS; Bhushan S; Vishwakarma RA; Kumar A; Bharate SB
Eur J Med Chem; 2016 Jan; 107():1-11. PubMed ID: 26560048
[TBL] [Abstract][Full Text] [Related]
8. Total Syntheses and Preliminary Biological Evaluation of Brominated Fascaplysin and Reticulatine Alkaloids and Their Analogues.
Zhidkov ME; Smirnova PA; Tryapkin OA; Kantemirov AV; Khudyakova YV; Malyarenko OS; Ermakova SP; Grigorchuk VP; Kaune M; Amsberg GV; Dyshlovoy SA
Mar Drugs; 2019 Aug; 17(9):. PubMed ID: 31450717
[TBL] [Abstract][Full Text] [Related]
9. Autophagy represses fascaplysin-induced apoptosis and angiogenesis inhibition via ROS and p8 in vascular endothelia cells.
Meng N; Mu X; Lv X; Wang L; Li N; Gong Y
Biomed Pharmacother; 2019 Jun; 114():108866. PubMed ID: 30999113
[TBL] [Abstract][Full Text] [Related]
10. Alkaloids of fascaplysin are promising chemotherapeutic agents for the treatment of glioblastoma: Review.
Lyakhova I; Piatkova M; Gulaia V; Romanishin A; Shmelev M; Bryukhovetskiy A; Sharma A; Sharma HS; Khotimchenko R; Bryukhovetskiy I
Int Rev Neurobiol; 2020; 151():299-324. PubMed ID: 32448613
[TBL] [Abstract][Full Text] [Related]
11. Anticancer Activity of Fascaplysin against Lung Cancer Cell and Small Cell Lung Cancer Circulating Tumor Cell Lines.
Rath B; Hochmair M; Plangger A; Hamilton G
Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30322180
[TBL] [Abstract][Full Text] [Related]
12. Fascaplysin induces caspase mediated crosstalk between apoptosis and autophagy through the inhibition of PI3K/AKT/mTOR signaling cascade in human leukemia HL-60 cells.
Kumar S; Guru SK; Pathania AS; Manda S; Kumar A; Bharate SB; Vishwakarma RA; Malik F; Bhushan S
J Cell Biochem; 2015 Jun; 116(6):985-97. PubMed ID: 25561006
[TBL] [Abstract][Full Text] [Related]
13. Fascaplysin Exerts Anti-Cancer Effects through the Downregulation of Survivin and HIF-1α and Inhibition of VEGFR2 and TRKA.
Oh TI; Lee YM; Nam TJ; Ko YS; Mah S; Kim J; Kim Y; Reddy RH; Kim YJ; Hong S; Lim JH
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28961193
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and new DNA targeting activity of 6- and 7-tert-butylfascaplysins.
Dyshlovoy SA; Mansour WY; Ramm NA; Hauschild J; Zhidkov ME; Kriegs M; Zielinski A; Hoffer K; Busenbender T; Glumakova KA; Spirin PV; Prassolov VS; Tilki D; Graefen M; Bokemeyer C; von Amsberg G
Sci Rep; 2024 May; 14(1):11788. PubMed ID: 38783016
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic effects of fascaplysin against small cell lung cancer cell lines.
Hamilton G
Mar Drugs; 2014 Mar; 12(3):1377-89. PubMed ID: 24608973
[TBL] [Abstract][Full Text] [Related]
16. Fascaplysin exert anti-tumor effects through apoptotic and anti-angiogenesis pathways in sarcoma mice model.
Yan X; Chen H; Lu X; Wang F; Xu W; Jin H; Zhu P
Eur J Pharm Sci; 2011 Jul; 43(4):251-9. PubMed ID: 21569843
[TBL] [Abstract][Full Text] [Related]
17. 9-Methylfascaplysin Is a More Potent Aβ Aggregation Inhibitor than the Marine-Derived Alkaloid, Fascaplysin, and Produces Nanomolar Neuroprotective Effects in SH-SY5Y Cells.
Sun Q; Liu F; Sang J; Lin M; Ma J; Xiao X; Yan S; Naman CB; Wang N; He S; Yan X; Cui W; Liang H
Mar Drugs; 2019 Feb; 17(2):. PubMed ID: 30781608
[TBL] [Abstract][Full Text] [Related]
18. The Marine-Derived Kinase Inhibitor Fascaplysin Exerts Anti-Thrombotic Activity.
Ampofo E; Später T; Müller I; Eichler H; Menger MD; Laschke MW
Mar Drugs; 2015 Nov; 13(11):6774-91. PubMed ID: 26569265
[TBL] [Abstract][Full Text] [Related]
19. Fascaplysin, a selective CDK4 inhibitor, exhibit anti-angiogenic activity in vitro and in vivo.
Lin J; Yan XJ; Chen HM
Cancer Chemother Pharmacol; 2007 Mar; 59(4):439-45. PubMed ID: 16816972
[TBL] [Abstract][Full Text] [Related]
20. New fascaplysin-based CDK4-specific inhibitors: design, synthesis and biological activity.
Aubry C; Jenkins PR; Mahale S; Chaudhuri B; Maréchal JD; Sutcliffe MJ
Chem Commun (Camb); 2004 Aug; (15):1696-7. PubMed ID: 15278142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
